tiprankstipranks
Phibro Animal Health (DE:PB8)
FRANKFURT:PB8
Germany Market
PB8
Phibro Animal Health
RESEARCH TOOLSreports

Phibro Animal Health (PB8) Ratios

1 Followers

Phibro Animal Health Ratios

DE:PB8's free cash flow for Q4 2026 was $0.34. For the 2026 fiscal year, DE:PB8's free cash flow was decreased by $ and operating cash flow was $0.11. See a summary of the company’s cash flow.
Ratios
TTM
Jun 26Jun 25Jun 24Jun 23
Liquidity Ratios
Current Ratio
 2.96 2.96 2.76 2.94 3.33
Quick Ratio
 1.27 1.27 1.25 1.64 1.75
Cash Ratio
 0.19 0.19 0.23 0.35 0.23
Solvency Ratio
 0.14 0.14 0.09 0.05 0.10
Operating Cash Flow Ratio
 0.22 0.22 0.27 0.43 0.08
Short-Term Operating Cash Flow Coverage
 2.76 2.76 4.93 2.94 0.60
Net Current Asset Value
$ -180.26M$ -180.26M$ -264.61M$ -124.55M$ -103.17M
Leverage Ratios
Debt-to-Assets Ratio
 0.53 0.53 0.56 0.53 0.52
Debt-to-Equity Ratio
 2.05 2.05 2.67 2.05 1.81
Debt-to-Capital Ratio
 0.67 0.67 0.73 0.67 0.64
Long-Term Debt-to-Capital Ratio
 0.65 0.65 0.71 0.64 0.62
Financial Leverage Ratio
 3.89 3.89 4.76 3.83 3.44
Debt Service Coverage Ratio
 2.74 2.74 2.57 1.17 2.10
Interest Coverage Ratio
 4.17 4.17 3.32 2.43 4.00
Debt to Market Cap
 0.50 0.57 0.69 0.71 0.86
Interest Debt Per Share
 20.60 20.60 19.62 13.52 13.03
Net Debt to EBITDA
 3.08 3.08 4.72 6.59 4.42
Profitability Margins
Gross Profit Margin
33.71%33.71%30.85%30.77%30.50%
EBIT Margin
12.18%12.18%7.81%3.23%7.36%
EBITDA Margin
15.58%15.58%11.33%6.79%10.84%
Operating Profit Margin
13.07%13.07%8.52%5.24%7.35%
Pretax Profit Margin
9.05%9.05%5.25%1.07%5.53%
Net Profit Margin
6.57%6.57%3.72%0.24%3.33%
Continuous Operations Profit Margin
6.57%6.57%3.72%0.24%3.33%
Net Income Per EBT
72.60%72.60%70.98%22.13%60.30%
EBT Per EBIT
69.21%69.21%61.55%20.47%75.26%
Return on Assets (ROA)
6.64%6.64%3.55%0.25%3.36%
Return on Equity (ROE)
28.67%25.87%16.89%0.94%11.54%
Return on Capital Employed (ROCE)
16.75%16.75%10.35%6.85%9.03%
Return on Invested Capital (ROIC)
11.81%11.81%7.18%1.45%5.26%
Return on Tangible Assets
7.07%7.07%3.82%0.27%3.78%
Earnings Yield
6.83%7.82%4.67%0.35%5.88%
Efficiency Ratios
Receivables Turnover
 6.36 6.36 5.69 6.01 5.98
Payables Turnover
 7.90 7.90 6.49 8.23 9.20
Inventory Turnover
 1.88 1.88 2.02 2.65 2.45
Fixed Asset Turnover
 4.11 4.11 3.27 4.22 4.23
Asset Turnover
 1.01 1.01 0.95 1.04 1.01
Working Capital Turnover Ratio
 2.47 2.67 2.84 2.52 2.49
Cash Conversion Cycle
 205.35 205.35 188.90 154.20 170.42
Days of Sales Outstanding
 57.41 57.41 64.20 60.78 61.02
Days of Inventory Outstanding
 194.15 194.15 180.99 137.75 149.07
Days of Payables Outstanding
 46.21 46.21 56.28 44.33 39.66
Operating Cycle
 251.56 251.56 245.19 198.53 210.09
Cash Flow Ratios
Operating Cash Flow Per Share
 1.70 1.70 1.98 2.16 0.33
Free Cash Flow Per Share
 0.24 0.24 1.03 1.14 -0.95
CapEx Per Share
 1.46 1.46 0.95 1.02 1.28
Free Cash Flow to Operating Cash Flow
 0.14 0.14 0.52 0.53 -2.89
Dividend Paid and CapEx Coverage Ratio
 0.88 0.88 1.39 1.44 0.19
Capital Expenditure Coverage Ratio
 1.17 1.17 2.09 2.12 0.26
Operating Cash Flow Coverage Ratio
 0.09 0.09 0.11 0.17 0.03
Operating Cash Flow to Sales Ratio
 0.05 0.05 0.06 0.09 0.01
Free Cash Flow Yield
0.68%0.77%4.04%6.72%-6.94%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 14.61 12.76 21.46 285.67 17.02
Price-to-Sales (P/S) Ratio
 0.96 0.84 0.80 0.68 0.57
Price-to-Book (P/B) Ratio
 3.79 3.31 3.62 2.69 1.96
Price-to-Free Cash Flow (P/FCF) Ratio
 147.67 129.22 24.73 14.89 -14.42
Price-to-Operating Cash Flow Ratio
 21.16 18.49 12.91 7.88 41.69
Price-to-Earnings Growth (PEG) Ratio
 0.14 0.12 0.01 -3.09 -0.51
Price-to-Fair Value
 3.79 3.31 3.62 2.69 1.96
Enterprise Value Multiple
 9.24 8.47 11.77 16.58 9.65
Enterprise Value
 2.18B 2.00B 1.73B 1.15B 1.02B
EV to EBITDA
 9.24 8.47 11.77 16.58 9.65
EV to Sales
 1.44 1.32 1.33 1.13 1.05
EV to Free Cash Flow
 221.40 202.94 41.31 24.70 -26.60
EV to Operating Cash Flow
 31.68 29.04 21.57 13.07 76.90
Tangible Book Value Per Share
 7.28 7.28 4.68 3.88 4.30
Shareholders’ Equity Per Share
 9.49 9.49 7.05 6.34 6.97
Tax and Other Ratios
Effective Tax Rate
 0.27 0.27 0.29 0.78 0.40
Revenue Per Share
 37.39 37.39 32.01 25.13 24.14
Net Income Per Share
 2.46 2.46 1.19 0.06 0.81
Tax Burden
 0.73 0.73 0.71 0.22 0.60
Interest Burden
 0.74 0.74 0.67 0.33 0.75
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.21 0.21 0.22 0.00 0.00
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 0.00
Income Quality
 0.69 0.69 1.66 36.26 0.41
Currency in USD